Dane Schroeder, EVP of Payer & Access Communications at BGB Group, explores the growing impact of “policy fatigue” as affordability pressures rise and traditional coverage pathways struggle to keep pace with innovation.
In this episode, Schroeder shares how pharma organizations can rethink access strategy, pricing models, and patient support to close the gap between coverage and real-world access.
Key Takeaways
- Understand how “policy fatigue” is shaping access, affordability, and coverage decisions
- Identify the key disconnects between formulary coverage and real patient access
- Examine how organizations are adapting access, pricing, and patient support in a rapidly evolving environment
